PORTOLA VALLEY, Calif., Nov. 2, 2010 /PRNewswire/ — Spectros
Corporation presented new clinical results using tissue oxygen
saturation with the T-Stat VLS Tissue Oximeter at the San Diego
Convention Center during Anesthesiology 2010. This newly released
data was presented during poster sessions entitled “Experimental
Circulation: Ischemia and Reperfusion” and “Clinical Circulation:
Pharmacology/Physiology”, held at the American Society of
Anesthesiologists (ASA 2010) on October 16, 2010 in San Diego, CA.
The studies were both conducted at Loma Linda University Medical
Center in Loma Linda, CA.
Loma Linda is just one of the newest locations across the US who
is relying on the T-Stat to improve the standard of care and help
cut costs. The abstracts, titled, “Regional Tissue Oxygen
Saturation in an Animal Model of Global and Regional Oxygen
Delivery Insults” and “Esophageal and Buccal Mucosal Oxygen
Saturation in Patients Undergoing Cardio-Pulmonary Bypass,” help
with the ability to assess oxygen delivery to an organ system to
provide a more sensitive mode to detect critical disease.
The T-Stat VLS technology can be easily used to monitor the
tissue oxygen saturation in numerous locations in the body with a
selection of sensors. This concept of monitoring tissue perfusion
is not new to the market, however T-Stat’s successful and patented
VLS white light technology is.
New findings within modern medicine are requiring more modern
technologies to assist in tougher diagnosis and more challenging
cases. The T-Stat fills this need with the ability to respond
within seconds to changes in tissue perfusion, allowing for real
time management of fluid status, cardiac output, and impending
shock during surgery, post-operatively, and in the ICU.
“Doctors continue to be enthusiastic about T-Stat’s superior
performance when compared directly to other tissue oximetry
products. We are pleased that T-Stat is gaining momentum in